HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glicentin

A 69-amino acid peptide derived from the N-terminal of PROGLUCAGON. It is mainly produced by the INTESTINAL L CELLS. Further processing of glicentin yield a 30-amino acid N-terminal peptide (glicentin-related polypeptide) and a 37-amino acid peptide OXYNTOMODULIN. Both glicentin and oxyntomodulin can reduce digestive secretions and delay gastric emptying.
Also Known As:
Glicentine; Proglucagon (1-69)
Networked: 51 relevant articles (0 outcomes, 7 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Mantzoros, Christos S: 3 articles (01/2021 - 12/2019)
2. Nielsen, Mette S: 3 articles (01/2021 - 01/2020)
3. Perakakis, Nikolaos: 3 articles (01/2021 - 12/2019)
4. Ritz, Christian: 3 articles (01/2021 - 01/2020)
5. Sjödin, Anders: 3 articles (01/2021 - 01/2020)
6. Wewer Albrechtsen, Nicolai J: 3 articles (01/2021 - 01/2020)
7. le Roux, Carel W: 3 articles (01/2021 - 01/2020)
8. Holm, Lotte: 2 articles (01/2021 - 11/2020)
9. Lunn, Susanne: 2 articles (01/2021 - 11/2020)
10. Schmidt, Julie Berg: 2 articles (01/2021 - 11/2020)

Related Diseases

1. Obesity
2. Neoplasms (Cancer)
3. Hypoglycemia (Reactive Hypoglycemia)
4. Infections
5. Non-alcoholic Fatty Liver Disease

Related Drugs and Biologics

1. Glucagon (Glukagon)
2. Oxyntomodulin
3. Glucagon-Like Peptide 1 (GLP 1)
4. Proglucagon (Glucagon Precursors)
5. Insulin (Novolin)
6. Glucagon-Like Peptides (Enteroglucagon)
7. glucagon-like-immunoreactivity
8. Follistatin
9. Activins (Activin)
10. Insulin-Like Growth Factor Binding Proteins

Related Therapies and Procedures

1. Bariatric Surgery
2. Gastric Bypass (Roux-en-Y Gastric Bypass)
3. Enteral Nutrition (Feeding, Tube)